more recent treatment eras (characterized by early diagnosis of RA and a treat-to-target approach) were included in the evidence report and may be less generalizable than more recently completed studies. Although broad expertise was recruited and an extensive list of interventions was considered in this guideline, we could not ensure expertise in every area of integrative RA management or consider all possible integrative interventions. For example, members of the Patient Panel inquired about